These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3617298

  • 1. Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
    Smith JB, Ghayad PY, Dhabuwala CB, Drelichman A, Pierce JM.
    Urology; 1987 Aug; 30(2):143-6. PubMed ID: 3617298
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
    Graham SD, Walker A, Cox EB, Laszlo J, Berry WR, Paulson DF.
    Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR, Goldman LB, Gershwin ME.
    Cancer; 1980 Jul 15; 46(2):273-8. PubMed ID: 7388771
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
    Wozniak AJ, Blumenstein BA, Crawford ED, Boileau M, Rivkin SE, Fletcher WS.
    Cancer; 1993 Jun 15; 71(12):3975-8. PubMed ID: 8508363
    [Abstract] [Full Text] [Related]

  • 7. Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats.
    Rosenberg CA, Hrushesky WJ, Langevin T, Kennedy BJ.
    Oncology; 1985 Jun 15; 42(1):48-54. PubMed ID: 3969257
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic interactions of cyclophosphamide and 5-fluorouracil with methotrexate in an animal model.
    de Bruijn EA, Driessen O, Leeflang P, van den Bosch N, van Strijen E, Slee PH, Hermans J.
    Cancer Treat Rep; 1986 Oct 15; 70(10):1159-65. PubMed ID: 3756938
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
    Kimura M, Tominaga T, Takatsuka Y, Toi M, Abe R, Koyama H, Takashima S, Nomura Y, Miura S, Kimijima I, Tashiro H, Ohashi Y, Adjuvant CEF Research Group for Breast Cancer.
    Breast Cancer; 2010 Jul 15; 17(3):190-8. PubMed ID: 19575284
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
    Block NL, Camuzzi F, Denefrio J, Troner M, Claflin A, Stover B, Politano VA.
    Oncology; 1977 Jul 15; 34(3):110-3. PubMed ID: 917440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR, Goldman L, Gershwin ME.
    Invest Urol; 1980 Jul 15; 18(1):80-1. PubMed ID: 7410017
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R, Bonadonna G, Valagussa P, Zambetti M.
    J Clin Oncol; 1991 Dec 15; 9(12):2134-40. PubMed ID: 1960555
    [Abstract] [Full Text] [Related]

  • 19. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D, Cappelaere P, Delobelle A, Depadt G, Madelain M, Demaille A.
    LARC Med; 1984 Nov 15; 4(9):532-40. PubMed ID: 6549038
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy in the treatment of adenocarcinoma of unknown primary origin.
    Walach N, Horn Y.
    Cancer Treat Rep; 1987 Jun 15; 71(6):605-7. PubMed ID: 3581098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.